1. Circulating natural killer cells in patients with symptomatic atherosclerosis acquire the CD9+CD49A pro-inflammatory phenotype and support M1-like macrophage polarization. (August 2022) Authors: Cucchiara, M.; Gallazzi, M.; Losa, S.; Carlini, V.; Mazzullo, T.; Martelli, M.; Noonan, D.M.; Bruno, A.; Albini, A. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗